BOCCELLATO, ELIA
 Distribuzione geografica
Continente #
NA - Nord America 376
EU - Europa 141
AS - Asia 119
SA - Sud America 1
Totale 637
Nazione #
US - Stati Uniti d'America 374
IT - Italia 49
CN - Cina 45
SG - Singapore 45
IE - Irlanda 31
SE - Svezia 19
UA - Ucraina 10
FI - Finlandia 9
IN - India 7
VN - Vietnam 6
FR - Francia 5
ID - Indonesia 5
BY - Bielorussia 4
DE - Germania 4
KR - Corea 4
PL - Polonia 4
HK - Hong Kong 3
CA - Canada 2
RO - Romania 2
AR - Argentina 1
AT - Austria 1
BE - Belgio 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
PT - Portogallo 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 637
Città #
Chandler 78
Santa Clara 56
Singapore 41
Dublin 31
Fairfield 19
Ashburn 11
Turin 11
Houston 10
Beijing 9
Columbus 9
Helsinki 9
Nyköping 9
Torino 9
Ann Arbor 7
Hangzhou 7
Medford 7
Princeton 7
Guangzhou 6
New York 6
Seattle 6
Cambridge 5
Chennai 5
Jakarta 5
Wilmington 5
Bologna 4
Canelli 4
Dong Ket 4
Jacksonville 4
San Diego 4
San Mateo 4
Seoul 4
Warsaw 4
Fremont 3
Guiyang 3
Hong Kong 3
Redwood City 3
Upper Marlboro 3
Boston 2
Chieri 2
Hebei 2
Milan 2
Munich 2
Nanjing 2
Naples 2
Norwalk 2
Rome 2
Woodbridge 2
Aiello Del Sabato 1
Bad Endorf 1
Brussels 1
Buenos Aires 1
Chengdu 1
Chicago 1
Dongguan 1
East Brunswick 1
Falkenstein 1
Fort Collins 1
Izmir 1
Jaipur 1
Jinan 1
Leawood 1
Los Angeles 1
Montreal 1
Pune 1
Quinta Do Conde 1
Riverton 1
Silver Spring 1
Toronto 1
Venezia 1
Vienna 1
Washington 1
Totale 459
Nome #
Pre-existing and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 108
Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs 107
Real life use of bendamustine in elderly patients with lymphoid neoplasia 100
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll 79
Modulation of Phenotypic and Functional Features of Immune Cells in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib 74
Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia 63
Impact of immune parameters and immune dysfunctions on the prognosis of patients with chronic lymphocytic leukemia 60
Beyond ibrutinib: novel BTK inhibitors for the treatment of chronic lymphocytic leukemia 35
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia 30
Totale 656
Categoria #
all - tutte 2.467
article - articoli 0
book - libri 0
conference - conferenze 276
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.743


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 0 0 1 5
2020/2021108 1 4 3 7 16 4 10 10 13 4 2 34
2021/2022129 9 7 12 6 10 2 10 2 4 12 29 26
2022/2023172 19 18 3 16 14 42 9 11 24 3 6 7
2023/202482 10 15 5 3 2 21 0 3 1 6 8 8
2024/2025159 3 6 11 31 71 37 0 0 0 0 0 0
Totale 656